Biomarkers in the management of heart failure

Published

Journal Article (Review)

Opinion statement: Biomarkers, especially natriuretic peptides such as B-type natriuretic peptide (BNP) and N-terminal-proBNP (NT-proBNP), are a valuable addition to standard clinical assessment in the diagnosis and prognosis of heart failure (HF). Furthermore, there is an increasing amount of evidence suggesting that natriuretic peptide-guided HF management may improve mortality, morbidity, and cost effectiveness. This work focuses on the use of BNP or NT-proBNP for the outpatient management of patients with chronic HF. © 2010 Springer Science+Business Media, LLC.

Full Text

Duke Authors

Cited Authors

  • Kim, HN; Januzzi, JL

Published Date

  • December 1, 2010

Published In

Volume / Issue

  • 12 / 6

Start / End Page

  • 519 - 531

International Standard Serial Number (ISSN)

  • 1092-8464

Digital Object Identifier (DOI)

  • 10.1007/s11936-010-0096-3

Citation Source

  • Scopus